Probiotics in prevention of IgE-associated eczema: A double-blind, randomized, placebo-controlled trial

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 5, 2007, Pages 1174-1180

  Abrahamsson, Thomas R ^a   Jakobsson, Ted ^a   Böttcher, Malin Fagerås ^a   Fredrikson, Mats ^b   Jenmalm, Maria C ^a   Björkstén, Bengt ^c   Oldaeus, Göran ^d  

^a Division of Pediatrics ^*  (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d RYHOV COUNTY HOSPITAL   (Sweden)

Author keywords

Children; eczema; IgE; Lactobacillus; prevention; probiotics; sensitization; skin prick test

Indexed keywords

FOOD ALLERGEN; IMMUNOGLOBULIN E; PLACEBO; PROBIOTIC AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECZEMA; FAMILY HISTORY; FEMALE; GESTATION PERIOD; HUMAN; INFANT; LACTOBACILLUS REUTERI; MAJOR CLINICAL STUDY; MALE; PRICK TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIZATION; WHEEZING;

CHILD, PRESCHOOL; ECZEMA; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INFANT; INFANT, NEWBORN; LACTOBACILLUS REUTERI; MALE; PREGNANCY; PROBIOTICS; SKIN TESTS;

EID: 34247502904     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.01.007     Document Type: Article

References (35)

1. Holt P.G., and Björkstén B. Atopic versus infectious diseases in childhood: a question of balance?. Pediatr Allergy Immunol 8 (1997) 53-58
2. Björkstén B., Naaber P., Sepp E., and Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 29 (1999) 1-5
3. Kalliomäki M., Kirjavainen P.V., Eerola E., Kero P., Salminen S.J., and Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107 (2001) 129-134
4. Sepp E., Julge K., Vasar M., Naaber P., Björkstén B., and Mikelsaar M. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 86 (1997) 956-961
5. Adlerberth I., Carlsson B., de Man P., Jalil F., Khan S.R., and Larsson P. Intestinal colonization with Enterobacteriaceae in Pakistani and Swedish hospital delivered infants. Acta Paediatr 80 (1991) 602-610
6. Alfvén T., Braun-Fahrländer C.H., Brunekreef B., von Mutius E., Riedler J., Scheynius A., et al. Allergic diseases and atopic sensitization in children related to farming and anthroprosophic lifestyle-the PARSIFAL study. Allergy 61 (2006) 414-421
7. Böttcher M.F., Björkstén B., Gustafsson S., Voor T., and Jenmalm M.C. Endotoxin levels in Estonian and Swedish house dust and atopy in infancy. Clin Exp Allergy 33 (2003) 295-300
8. McKeever T.M., Lewis S.A., Smith C., Collins J., Heatlie H., Frischer M., et al. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. J Allergy Clin Immunol 109 (2002) 43-50
9. Guarner F., and Schaafsma G.J. Probiotics. Int J Food Microbiol 39 (1998) 237-238
10. Isolauri E., Arvola T., Sütas Y., Moilanen E., and Salminen S.J. Probiotics in the management of atopic eczema. Clin Exp Allergy 30 (2000) 1604-1610
11. Rosenfeldt V., Benfeldt E., Dam Nielsen S., Fleischler Michaelsen K., Jeppesen D.L., Valerius N.H., et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111 (2003) 389-395
12. Weston S., Halbert A., Richmond P., and Prescott S. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 90 (2005) 892-897
13. Kalliomäki M., Salminen S.J., Arvilommi H., Kero P., Koskinen P., and Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357 (2001) 1076-1079
14. Kalliomäki M., Salminen S.J., Poussa T., Arvilommi H., and Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361 (2003) 1869-1871
15. Ma D., Forsythe P., and Bienenstock J. Live Lactobacillus reuteri is essential for the inhibitory effect on tumour necrosis factor alpha-induced Interleukin-8 expression. Infect Immun 72 (2004) 5308-5314
16. Peňa J., Rogers A., Ge Z., Ng V., Li S., Fox J., et al. Probiotic Lactobacillus spp diminish Helicobacter hepaticus-induced inflammatory bowel disease in Interleukin-10-deficient mice. Infect Immun 73 (2005) 912-920
17. Smits H., Engering A., van der Kleij D., de Jong E., Schipper K., van Capel T., et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 115 (2005) 1260-1267
18. Shornikova A.V., Casas I.A., Mykkänen H., Salo E., and Vesikari T. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 16 (1997) 1103-1107
19. Shornikova A.V., Casas I.A., Isolauri E., Mykkänen H., and Vesikari T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr 24 (1996) 399-404
20. Eom T.-H., Oh E.-Y., Kim Y.-H., Lee H.-S., Jang P.S., Kim D.-U., et al. The therapeutic effect of Lactobacillus reuteri in acute diarrhea in infants and toddlers. Korean J Pediatr 48 (2005) 986-990
21. Weizman Z., Asli G., and Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115 (2005) 5-9
22. Valeur N., Engel P., Carbajal N.Y., Connolly E., and Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the Human Gastrointestinal Tract. Appl Environ Microbiol 70 (2003) 1176-1181
23. Wolf B.W., Garleb K.A., Ataya D.G., and Casas I.A. Safety and tolerance of Lactobacillus reuteri in healthy adult male subjects. Microbial Ecol Health 8 (1995) 41-50
24. Wolf B.W., Wheeler K.B., Ataya D.G., and Garleb K.A. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the Human Immunodeficiency Virus. Food Chem Toxicol 36 (1998) 1085-1094
25. Severity Scoring of Atopic Dermatitis: The SCORAD index. Consensus report from the of the European Task Force on atopic dermatitis. Dermatology 186 (1993) 23-31
26. Seymore J., Keswick B., Hanifin J.M., Jordan P., and Milligan M. Clinical effects of diaper types on skin of normal infants and infants with atopic dermatitis. J Am Acad Dermatol 17 (1987) 988-997
27. Liu C.A., Wang C.L., Chuang H., Ou C.Y., Csu T.Y., and Yang K.D. Prenatal prediction of infant atopy by maternal but not paternal total IgE levels. J Allergy Clin Immunol 112 (2003) 899-904
28. Sigurs N., Hattevig G., Kjellman B., Kjellman N.I., Nilsson L., and Björksten B. Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years. J Allergy Clin Immunol 94 (1994) 757-763
29. Novembre E., Cianferoni A., Lombardi E., Bernardini R., Pucci N., and Vierucci A. Natural history of "intrinsic" atopic dermatitis. Allergy 56 (2001) 452-453
30. Viljanen M., Savilahti E., Haahtela T., Juntunen-Backman K., Korpela R., Poussa T., et al. Probiotics in treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60 (2005) 494-500
31. Brouwer M.L., Wolt-Plompen S.A., Dubois A.E., van der Heide S., Jansen D.F., Hoijer M.A., et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 36 (2006) 899-906
32. Vaarala O. Immunological effects of probiotics with special reference to lactobacilli. Clin Exp Allergy 33 (2003) 1634-1640
33. Zeuthen L., Christensen H.R., and Frøkiær H. Lactic acid bacteria inducing a weak Interleukin-12 and Tumour Necrosis Factor Alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram negative bacteria. Clin Vaccine Immunol 13 (2005) 365-375
34. Jacobsen C.N., Rosenfeldt Nielsen V., Hayford A.E., Møller P.L., Michaelsen K.F., Pærregaard A., et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 65 (1999) 4949-4956
35. Taylor A.L., Dunstan J.A., and Prescott S.L. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 119 (2007) 184-191